PHAT · Phathom Pharmaceuticals, Inc.
Market Cap
$768.56M
Shares
80.90M
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.
Key facts
CIK
1783183
CUSIP
71722W107
13F (30d)
120 filings
120 filers
Visit website
Investor relations